Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging.
Recent technical advances in computed tomography (CT; helical and electron beam) and magnetic resonance (MR) imaging have spurred a renewed interest in these modalities for the diagnosis of acute and chronic pulmonary embolism (PE). These techniques can enable accurate clot detection down to segmental pulmonary arteries, with CT currently allowing more accuracy than that with MR imaging. Ongoing technical advances, particularly in MR angiography, will likely increase diagnostic accuracy. Inability to reliably detect subsegmental acute emboli may not prove to be a clinically significant limitation if lung imaging is coupled with evaluation for deep venous thrombosis. MR imaging can potentially accomplish this within a single examination. Incorporation of CT and MR imaging into diagnostic algorithms for suspected PE can be cost-effective. Evaluation of these new modalities should be based on patient outcome, not solely on clot detectability. Well-designed clinical trials are warranted before CT and MR imaging can be used routinely in the diagnosis of acute PE.
D000208:Acute Disease; D000465:Algorithms; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D006801:Humans; D018810:Magnetic Resonance Angiography / Q000191:economics; D008279:Magnetic Resonance Imaging / Q000191:economics; D011651:Pulmonary Artery / Q000000981:diagnostic imaging / Q000473:pathology; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D015203:Reproducibility of Results; D013679:Technology, Radiologic; D013924:Thrombophlebitis / Q000175:diagnosis / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed / Q000191:economics; D016896:Treatment Outcome